Financial Results for the sixteen month period ended 30 September 2014

IXICO today announces its final results for the sixteen month period ended 30 September 2014.


  • During the period IXICO became a public company and continued its evolution in the emerging and fast moving digital healthcare market with a focus on brain health
  • Contracts signed with four significant new customers in a range of disease indications
  • New opportunities in Huntington’s disease specialisation
  • International commercial alliance with VirtualScopics Inc. signed in July enhances IXICO’s ability to provide clinical trial industry with global operational capabilities
  • IXICO selected as industry partner in Dementias Platform UK
  • Significant investment in digital health
  • Financial performance in line with market and board expectations
By |2017-10-11T11:54:28+00:0010 February 2015|Financial|